Association of the Tyrosine/Nitrotyrosine pathway with death or ICU admission within 30 days for patients with community acquired pneumonia

BMC Infectious Diseases
Thomas BaumgartnerPhilipp Schuetz

Abstract

Oxidative stress is a modifiable risk-factor in infection causing damage to human cells. As an adaptive response, cells catabolize Tyrosine to 3-Nitrotyrosine (Tyr-NO2) by nitrosylation. We investigated whether a more efficient reduction in oxidative stress, mirrored by a lowering of Tyrosine, and an increase in Tyr-NO2 and the Tyrosine/Tyr-NO2 ratio was associated with better clinical outcomes in patients with community-acquired pneumonia (CAP). We measured Tyrosine and Tyr-NO2 in CAP patients from a previous randomized Swiss multicenter trial. The primary endpoint was adverse outcome defined as death or ICU admission within 30-days; the secondary endpoint was 6-year mortality. Of 278 included CAP patients, 10.4% experienced an adverse outcome within 30 days and 45.0% died within 6 years. After adjusting for the pneumonia Severity Index [PSI], BMI and comorbidities, Tyrosine nitrosylation was associated with a lower risk for short-term adverse outcome and an adjusted OR of 0.44 (95% CI 0.20 to 0.96, p = 0.039) for Tyr-NO2 and 0.98 (95% CI 0.98 to 0.99, p = 0.043) for the Tyrosine/Tyr-NO2 ratio. There were no significant associations for long-term mortality over six-years for Tyr-NO2 levels (adjusted hazard ratio 0.81, 95% CI 0...Continue Reading

References

Nov 1, 1992·Archives of Biochemistry and Biophysics·H IschiropoulosJ S Beckman
Dec 1, 1992·Archives of Biochemistry and Biophysics·C D SmithJ S Beckman
Sep 1, 1990·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·H OhshimaH Bartsch
Mar 1, 1990·Mechanisms of Ageing and Development·H IschiropoulosY Kikkawa
Sep 23, 1994·Cell·C Nathan, Q W Xie
Sep 15, 1993·Biochemical and Biophysical Research Communications·S Padmaja, R E Huie
Jan 1, 1997·Free Radical Biology & Medicine·N FukuyamaH Nakazawa
Apr 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·X LiuJ R Lancaster
Mar 26, 2003·Free Radical Biology & Medicine·Stefan I Liochev, Irwin Fridovich
Dec 1, 1961·The Journal of Biophysical and Biochemical Cytology·G MAJNOG I SCHOEFL
Jun 1, 2005·Trends in Pharmacological Sciences·Pal PacherCsaba Szabó
Aug 9, 2005·Expert Opinion on Therapeutic Targets·Alexander J MullerGeorge C Prendergast
Feb 8, 2006·Applied and Environmental Microbiology·Shirley F Nishino, Jim C Spain
Jan 24, 2007·Physiological Reviews·Pál PacherLucas Liaudet
Sep 16, 2008·Therapeutische Umschau. Revue thérapeutique·Klaus M Weinberger
Jul 16, 2009·Journal of Cellular and Molecular Medicine·Anika MüllerWalter Däubener
Jul 28, 2009·Annual Review of Medicine·Miles BergerBryan L Roth
Sep 10, 2009·JAMA : the Journal of the American Medical Association·Philipp SchuetzUNKNOWN ProHOSP Study Group
Dec 29, 2009·Nature Genetics·Thomas IlligKarsten Suhre
Oct 1, 2011·Free Radical Biology & Medicine·Mary A RobinsonCynthia M Otto
Apr 22, 2016·Clinical Chemistry and Laboratory Medicine : CCLM·Manuela NicklerPhilipp Schuetz
Mar 25, 2017·Critical Care : the Official Journal of the Critical Care Forum·Manuela NicklerUNKNOWN ProHOSP Study Group

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT00350987

Software Mentioned

STATA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.